These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 23127990)

  • 21. Preparation and anticoagulation activity of sodium cellulose sulfate.
    Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY
    Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring the anti-Xa anticoagulants, from heparin to eliquis.
    Fritsma GA
    Clin Lab Sci; 2013; 26(1):48-53. PubMed ID: 23479837
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological actions of sulodexide.
    Ofosu FA
    Semin Thromb Hemost; 1998; 24(2):127-38. PubMed ID: 9579633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects.
    Harenberg J; Stehle G; Dempfle CE; von Hodenberg E; Heene DL
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):967-80. PubMed ID: 2483715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The binding behavior of cyclodextrins toward a nitroxide spin probe in the presence of different alcohols as studied by EPR.
    Franchi P; Pedulli GF; Lucarini M
    J Phys Chem A; 2008 Sep; 112(37):8706-14. PubMed ID: 18729439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dalteparin dose-dependently increases ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro study.
    Feuring M; Wehling M; Schultz A
    Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):783-6. PubMed ID: 21883380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitroxyl Modified Tobacco Mosaic Virus as a Metal-Free High-Relaxivity MRI and EPR Active Superoxide Sensor.
    Dharmarwardana M; Martins AF; Chen Z; Palacios PM; Nowak CM; Welch RP; Li S; Luzuriaga MA; Bleris L; Pierce BS; Sherry AD; Gassensmith JJ
    Mol Pharm; 2018 Aug; 15(8):2973-2983. PubMed ID: 29771534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation, Anticoagulant and Antioxidant Properties of Glucosamine-Heparin Salt.
    Miao Q; Li Q; Tan W; Mi Y; Ma B; Zhang J; Guo Z
    Mar Drugs; 2022 Oct; 20(10):. PubMed ID: 36286469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The uronic acid of heparin.
    CIFONELLI JA; DORFMAN A
    Biochem Biophys Res Commun; 1962 Feb; 7():41-5. PubMed ID: 13879525
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of stypturon on hemorrhagic tendency increased by anticoagulants].
    VODOPIVEC M
    Klin Wochenschr; 1954 Dec; 32(47-48):1112. PubMed ID: 13234295
    [No Abstract]   [Full Text] [Related]  

  • 31. Anticoagulant effects of antioxidant capacity.
    Rea CA; Maxwell SR; Maslin DJ; Thomason HL; Thorpe GH
    Ann Clin Biochem; 1996 Mar; 33 ( Pt 2)():174. PubMed ID: 8729733
    [No Abstract]   [Full Text] [Related]  

  • 32. Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy).
    Panova IG; Tatikolov AS
    Pharmaceuticals (Basel); 2023 Jul; 16(8):. PubMed ID: 37630992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting vascular (endothelial) dysfunction.
    Daiber A; Steven S; Weber A; Shuvaev VV; Muzykantov VR; Laher I; Li H; Lamas S; Münzel T
    Br J Pharmacol; 2017 Jun; 174(12):1591-1619. PubMed ID: 27187006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease.
    Steven S; Münzel T; Daiber A
    Int J Mol Sci; 2015 Aug; 16(8):18185-223. PubMed ID: 26251902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-polynitroxides: synthesis and preliminary evaluation as cardiovascular EPR/MR imaging probes and extracellular space-targeted antioxidants.
    Kleschyov AL; Sen' V; Golubev V; Münnemann K; Hinderberger D; Lackner KJ; Weber S; Terekhov M; Schreiber LM; Münzel T
    Eur J Med Chem; 2012 Dec; 58():265-71. PubMed ID: 23127990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-polynitroxide derivatives: a platform for new diagnostic and therapeutic agents in cardiovascular disease?
    Kleschyov AL; Sen' VD
    Future Med Chem; 2013 Mar; 5(4):385-8. PubMed ID: 23495686
    [No Abstract]   [Full Text] [Related]  

  • 38. Biological Relevance of Free Radicals and Nitroxides.
    Prescott C; Bottle SE
    Cell Biochem Biophys; 2017 Jun; 75(2):227-240. PubMed ID: 27709467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inclusion complexes of PBN-type nitrone spin traps and their superoxide spin adducts with cyclodextrin derivatives: parallel determination of the association constants by NMR titrations and 2D-EPR simulations.
    Bardelang D; Rockenbauer A; Karoui H; Finet JP; Tordo P
    J Phys Chem B; 2005 May; 109(20):10521-30. PubMed ID: 16852274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free radicals and antioxidants at a glance using EPR spectroscopy.
    Spasojević I
    Crit Rev Clin Lab Sci; 2011; 48(3):114-42. PubMed ID: 21875311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.